DataMatrix Medical’s Post

The MEDIN Business Plan for 2024-2029 sets out an ambitious and targeted programme to tackle the key data management objectives identified by our stakeholders in a changing data and technological landscape. By 2029, delivery of this plan will see MEDIN provide measurable benefits to the UK economy, providing services, tools and expert advice, agnostic of the sector our users work in. MEDIN will lead the marine data community and facilitate connections based on shared experience. Funded by a consortium of fifteen Sponsors and benefiting from in kind contributions from our committed network of Partners, MEDIN will use its annual budget to deliver the national framework for UK marine data. MEDIN’s strapline ‘measure once, use many times’, captures the ethos of MEDIN and has been adopted by other organisations and networks around the world. Find out more about the MEDIN Business Plan 👇https://hubs.la/Q02B3D5L0 #MEDINBusinessPlan2429 #marinedatasharing

🚀 Tired of the same old clinical tools? On June 27th, we’re dropping Castor’s hottest 2024 innovations. From ePRO upgrades to smarter data exports, we’re transforming research. Don’t miss out. Register now to listen in with Sébastien and Conal as they chat about our product plans for 2024 and beyond 👉 https://lnkd.in/e7HH_Krj #ClinicalResearch #ePRO #DataRevolution

Come meet our team at #WorldOrphanUSA to discuss how we can leverage #RWE to support your product's evidence generation plan!

MEDIN has been operational for 16 years and during the creation of the next MEDIN Business Plan, we took the time to reflect on some key milestones. From an initial group of four Data Archive Centres sharing 800 datasets in 2010 to a mature network that shares over 17,500 datasets owned or managed by more than 600 different organisations across sectors in 2023, is a remarkable feat. MEDIN’s aspirational and ambitious new 5-year business plan builds upon the successes of the past and will see MEDIN strengthen its position as an internationally-recognised authority on marine data management. By setting out a framework of strategic goals and deliverable activities, this plan captures MEDIN’s objectives and aspirations for its next half-decade. Find out more about the MEDIN Business Plan 👇https://hubs.ly/Q02BgQtm0 #MEDINBusinessPlan2429 #marinedatasharing

📣 GeneDx Second Quarter 2023 Financial Results and Business Highlights! The recent update underscores our strategic approach and the significant opportunity to reduce the diagnostic odyssey faced by patients and their families. #Q2Earnings #FinancialResults #EarningsCall #WGS

Discover the stories of those we serve. Today, we shine a spotlight on Centurion Labs, LLC. Thank you for choosing Cogent Analytics as your trusted partner. To read more, click here:https://lnkd.in/eEqBasFY #businessconsulting #RaiseOthersUp #DecadeOfDifference

Wondering how to leverage observational data to conduct comparative effectiveness research that's as rigorous and insightful as a randomized controlled trial? Meet CERBOT: the tool that's changing the game for Comparative Effectiveness Research. Designed for researchers and clinicians, CERBOT simplifies the process of using observational data to emulate target trials, guiding you through five key modules to articulate and evaluate your research questions effectively. With CERBOT, you can collaborate easily, sharing ideas and refining your approach to achieve rigorous, insightful outcomes. 🔗 Learn more about CERBOT and start enhancing your research by visiting their site: http://cerbot.org/. 🌟 Interested in 'Target Trial Emulation'? Connect with SporeData Inc. (www.sporedata.com) for insights and support in advancing your research. #ComparativeEffectivenessResearch #ObservationalData #CERBOT #TargetTrialEmulation #DataScience #collaboratewithsporedata

Delighted to announce our participation at the PHUSE US Connect! Explore with us as we uncover the power of graph databases in streamlining clinical trial data management, from study planning to archiving.  Learn firsthand the significance of integrated metadata for optimizing trial processes. Don't miss out! Join our presentation (ET22) on "The Potential Power of Data" and visit our poster session (PP13) titled "Harnessing the Data's Potential in a Clinical Trial Process."  See you there! #phuseusconnect #clinicalscience #graphdata #fairdata

At Moxe, we’re kicking off 2024 refreshed and ready to dig in and advance clinical data exchange. In a note to the Moxe community, our CEO, Dan Wilson, summarized our collective outlook for the coming year, “Now, more than ever, I am hopeful that meaningful clinical data exchange can and will increase efficiency; unite payers and providers for more informed, meaningful collaboration; and improve clinical and financial outcomes.” Read Dan’s full note for more on Moxe’s goals, commitments, and focus as we step into a new year dedicated to our mission. https://hubs.li/Q02h0mjs0

Please join CEO Dave Marver and CFO Lara Smith Weber for our Half Year 2023 Business Update on September 19 at 2 PM CET. Register in advance for the webinar here: https://lnkd.in/dGsQMqrj After registering, you will receive a confirmation email containing joining instructions.   #EmpoweringMovement #SCI #MedTech #BusinessUpdate